APA (7th ed.) Citation

Bacher, U., Haferlach, T., Alpermann, T., Kern, W., Schnittger, S., & Haferlach, C. (2013). Molecular mutations are prognostically relevant in AML with intermediate risk cytogenetics and aberrant karyotype. Leukemia (08876924), 27(2), 496. https://doi.org/10.1038/leu.2012.200

Chicago Style (17th ed.) Citation

Bacher, U., T. Haferlach, T. Alpermann, W. Kern, S. Schnittger, and C. Haferlach. "Molecular Mutations Are Prognostically Relevant in AML with Intermediate Risk Cytogenetics and Aberrant Karyotype." Leukemia (08876924) 27, no. 2 (2013): 496. https://doi.org/10.1038/leu.2012.200.

MLA (9th ed.) Citation

Bacher, U., et al. "Molecular Mutations Are Prognostically Relevant in AML with Intermediate Risk Cytogenetics and Aberrant Karyotype." Leukemia (08876924), vol. 27, no. 2, 2013, p. 496, https://doi.org/10.1038/leu.2012.200.